ARTICLE
Volume 4,Issue 3
7 April 2025
To Analyze the Effect of Hemodialysis, Hemoperfusion, and Oral Olanzapine on Uremic Encephalopathy
Yueyue He
Show Less
1
Boe Hospital of Suzhou, Suzhou 215217, Jiangsu Province, China,
CNR 2025 , 3(1), 8–12;
https://doi.org/10.26689/cnr.v3i1.10140
© 2025 by the Authors. Licensee Whioce Publishing, Singapore. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract
Objective: To analyze the effects of hemodialysis, hemoperfusion, and oral olanzapine in patients with uremic encephalopathy. Methods: 70 patients with uremic encephalopathy admitted to the hospital from January 2023 to August 2024 were selected and divided into groups according to a random drawing method, with 35 cases in each group. The control group was treated with hemodialysis and olanzapine orally, and the observation group was treated with hemoperfusion. PANSS scores, biochemical indexes, and inflammatory factors were compared between the two groups. Results: PANSS score, biochemical indexes, and inflammatory factors in the observation group were significantly lower than those in the control group (P < 0.05). Conclusion: The triple therapy of hemodialysis, hemoperfusion, and olanzapine can obviously promote the improvement of the psychological state of the patients. In addition, this treatment can also relieve inflammation in the patients and accelerate the excretion of toxins in the body.
References
Zhou Q, Zheng L, Chen YL, et al., 2019, Effect of Hemodialysis, Hemoperfusion, and Olanzapine in the Treatment of Uremic Encephalopathy. Chinese Journal of Medical Innovation, 21(23): 45–48.
Zhang YA, Chen B, Wu CY, et al., 2019, Efficacy and Safety of Olanzapine Combined with Hemodialysis Filtration and HA330-Ⅱ Hemoperfusion in the Treatment of Uremic Encephalopathy. Journal of Qiqihar Medical College, 44(6): 525–528.
Wu ZF, Li ZS, Xie J, et al., 2019, Analysis of Risk Factors for Uremic Encephalopathy in Maintenance Hemodialysis Patients. Journal of Anhui Medicine, 26(12): 2493–2496.
Fang HM, 2022, The Clinical Study of Hemodialysis Filtration in the Treatment of Uremic Encephalopathy in Patients with End-stage Renal Disease. Heilongjiang Journal of Medicine, 35(3): 668–670.
Chen M, 2019, Effect Analysis of Hemodialysis Combined with Hemoperfusion in the Treatment of Uremic Encephalopathy. Chinese Medical Guide, 18(21): 119–120.
Wang ZN, 2019, Application Effect of Hemodialysis Combined with Hemoperfusion in Patients with Uremic Encephalopathy. Chinese Journal of Medical Sciences, 32(13): 50–52.
Wang NA, 2019, Observation of the Effect of Hemodialyxidation in the Treatment of Uremic Encephalopathy and Analysis of Effective Rate. Journal of Clinical Medical Literature Electronic, 7(32): 7–8.
Chen YL, Shen P, Sun DD, 2021, Effect of Hemodialysis Combined with Hemoperfusion in the Treatment of Uremic Encephalopathy and its Effect on Toxin Clearance, Nerve Function and Serum Neurofactors. International Journal of Transplantation and Blood Purification, 19(3): 4.
Zhao CG, Liang YM, 2020, Effect of Hemodialysis Combined with Hemoperfusion on Uremic Encephalopathy and its Effect on Serum Brain-derived Neurotrophic Factor and Neuropeptide Y. Chinese Community Physician, 36(17): 2.
An Y, 2019, Clinical Effect of Hemodialysis Combined with Hemoperfusion in the Treatment of Cephalosporin Encephalopathy in Uremia. Chinese Modern Drug Application, 14(4): 2.
Liu HY, 2021, Clinical Effect of Hemoperfusion Combined with Hemodialysis on Uremic Encephalopathy. Chinese Journal of Health Care, 39(12): 58–60.
Deng LS, 2019, Effect of Hemodialysis Combined with Hemoplavage on Skin Pruritus in Uremia. Chinese Journal of Continuing Medical Education, 12(25): 99–102.
Liu ZJ, Liu YQ, 2019, Effect of Hemodialysis Combined with Hemoperfusion on Hyperparathyroidism Secondary to Uremia. Chinese Journal of Modern Medicine, 21(2): 59–61.
Shi YH, 2929, Clinical Observation of Hemodialysiltration Combined with Hemoplavage in the Treatment of Uremic Encephalopathy. Health Friends, 2020(12): 69–70.
Li ZYN, 2020, Therapeutic Effect of Different Blood Purification on Drug-induced Encephalopathy in Patients with Uremia. Chinese Journal of Practical Medicine, 17(21): 57–59.
Liu YH, Wu Y, Zhang YN, et al., 2022, Effects of Combined Hemoperfusion and Peritoneal Dialysis on Levels of Blood Urea Nitrogen, Serum Creatinine and Hypersensitive C-reactive Protein in Patients with Uremic Encephalopathy. Chinese Journal of Clinical and Practical Medicine, 13(5): 5.
Liu YP, 2020, Clinical Observation of Hemodialysiltration Combined with Hemoplavage in the Treatment of Uremic Encephalopathy. Chinese Pharmaceutical Industry, 29(S2): 76–77.
Liu SG, 2020, Effect of Continuous Renal Replacement Therapy Combined with Hemoperfusion on Relevant Biochemical Indexes in Patients with Severe Uremic Encephalopathy. Journal of Chronic Medicine, 21(10): 1599–1601.
Deng XM, Huang HF, Yin XY, 2019, Research Progress of Integrated Chinese and Western Medicine in Uremic Encephalopathy. Modern Distance Education of Chinese Medicine, 22(19): 97–100.
Lin XR, Liang HQ, Cai MH, 2019, Clinical Efficacy of Different Blood Purification Methods in the Treatment of Uremic Encephalopathy and its Influence on Neurological Function. Journal of Modern Integrated Chinese and Western Medicine, 28(4): 403–406.
Share
Back to top
Bio-Byword Scientific Publishing Pty. Ltd.
We are committed to supporting the scientific community by publishing impactful research and fostering effective communication among scientists. We continuously seek ways to accelerate scientific progress while upholding transparency and open dialogue. Our goal is to make knowledge freely and barrier‑free accessible to all.
Contact us: info@bbwpublisher.com
Level 10, 50 Clarence Street Sydney, NSW 2000 Australia